NDC 80425-0288-01 - Topiramate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0288
- Requested NDC
- 80425-0288-01
- Package NDCs from labels
- 80425-0288-1, 80425-0288-2, 80425-0288-3, 80425-0288-4, 80425-0288-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Topiramate - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0288-1 | Topiramate | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 80425-0288-2 | Topiramate | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 3 | |
| 80425-0288-3 | Topiramate | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 | |
| 80425-0288-4 | Topiramate | 270 in 1 BOTTLE | TABLET, FILM COATED | 270 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0288 | TOPIRAMATE TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 4 package rows | 20250102_f781ada8-f90d-b233-e053-6394a90a87ff.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0288-1 | EA - Each | 80425-0288 | 9fbfba24-cf2a-4e1a-80a5-67637f87c9c7 | 1 | 2023-04-07 |
| 80425-0288-2 | EA - Each | 80425-0288 | 36543b72-ad68-45cd-9599-fb59429f30b5 | 1 | 2023-04-07 |
| 80425-0288-3 | EA - Each | 80425-0288 | 00c10f76-0d12-4caa-9194-58853a5a9c36 | 1 | 2023-04-07 |
| 80425-0288-4 | EA - Each | 80425-0288 | a332c281-bc27-4da9-9192-db431088f371 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | Camber Pharmaceuticals, Inc. | dbc52b16-b93d-4d83-942b-485c502db1fa | 2026-03-16 | Warnings, Adverse reactions | 0H73WJJ391 |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 7bc4ec7a-9b83-4842-9057-e1a804b2596d | 2026-03-13 | Warnings, Adverse reactions | 0H73WJJ391 |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 035bf713-1642-4215-83ec-0ed07c29f92c | 2026-03-13 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | C | 164cb1f7-1a41-675f-e063-6294a90ae0dd | 2026-03-05 | Warnings, Adverse reactions | 199889 0H73WJJ391 |
| Phentermine and topiramate | PHENTERMINE AND TOPIRAMATE | Teva Pharmaceuticals, Inc. | 918df93d-e033-4419-adcc-e21655ef8158 | 2026-03-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Advanced Rx of Tennessee, LLC | 4b1d3130-cf3c-d7da-e063-6294a90a6079 | 2026-02-18 | Warnings, Adverse reactions | ANDA090162 199888 0H73WJJ391 |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 7f1e4475-6326-47a3-a317-b04b74b7c109 | 2026-02-02 | Warnings, Adverse reactions | 199888 0H73WJJ391 |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 55e71f43-1cd5-4efc-9641-fda0a09c30f0 | 2026-02-02 | Warnings, Adverse reactions | 199888 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Dr. Reddys Laboratories Inc. | f07d81bc-5090-fbc5-2945-557cf002849c | 2026-02-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals Inc. | 68b22d22-c2d3-4e90-b302-56f7cb731427 | 2026-01-28 | Warnings, Adverse reactions | ANDA090162 199890 0H73WJJ391 |
| Topiramate | TOPIRAMATE | AvKARE | 25b377f7-ea89-fb56-e063-6394a90a239d | 2026-01-19 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | afd4c2b9-b80c-b43a-e053-2995a90ac923 | 2026-01-01 | Warnings, Adverse reactions | 199888 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ca45d478-7214-5bc7-e053-2995a90aa601 | 2026-01-01 | Warnings, Adverse reactions | 151226 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ae63e0e2-ceb1-4cc7-88fa-92cfa4516960 | 2026-01-01 | Warnings, Adverse reactions | 199889 0H73WJJ391 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | f3321dc5-0fb7-0d12-e053-2a95a90a9694 | 2026-01-01 | Warnings, Adverse reactions | 151226 0H73WJJ391 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | ffd7be08-050e-dfcb-e053-6394a90ad286 | 2026-01-01 | Warnings, Adverse reactions | 199889 0H73WJJ391 |
| Topiramate | TOPIRAMATE | Ascend Laboratories, LLC | cb966bcb-3af7-4dbe-b540-58d473b891e5 | 2025-12-18 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 1f327383-beb3-4d15-add6-5f1c749f2b3f | 2025-11-18 | Warnings, Adverse reactions | 199888 0H73WJJ391 |
| Eprontia | TOPIRAMATE | Azurity Pharmaceuticals, Inc. | e2a4df59-fead-4a01-9021-9eda02c48010 | 2025-11-13 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | A-S Medication Solutions | a5cffe7a-fdee-487a-bafb-a2d43e76c23c | 2025-11-10 | Warnings, Adverse reactions | ANDA090162 151226 199889 199888 0H73WJJ391 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.